These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7872247)

  • 21. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.
    Zehnder JL; Benson RC
    Am J Clin Pathol; 1996 Jul; 106(1):107-11. PubMed ID: 8701918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of storage conditions on activated protein C resistance assay.
    Trossaërt M; Conard J; Horellou MH; Samama MM
    Thromb Haemost; 1995 Jan; 73(1):163-4. PubMed ID: 7740489
    [No Abstract]   [Full Text] [Related]  

  • 26. Familial thrombophilia: a complex genetic disorder.
    Koeleman BP; Reitsma PH; Bertina RM
    Semin Hematol; 1997 Jul; 34(3):256-64. PubMed ID: 9241710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual genetic abnormality in the coagulation pathway as a cause of familial thrombophilia.
    Khaira A; Kalra OP; Gupta A; Khaira DD
    J Assoc Physicians India; 2009 Jul; 57():529-30. PubMed ID: 20329415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited homozygous resistance to activated protein C.
    Villa P; Aznar J; Jorquera J; Mira Y; Vayá A; Fernández MA
    Thromb Haemost; 1995 Aug; 74(2):794-5. PubMed ID: 8585025
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory diagnosis of resistance to activated protein C (APC-resistance).
    Bertina RM
    Thromb Haemost; 1997 Jul; 78(1):478-82. PubMed ID: 9198200
    [No Abstract]   [Full Text] [Related]  

  • 31. False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract.
    Martorell JR; Muñoz-Castillo A; Gil JL
    Thromb Haemost; 1995 Aug; 74(2):796-7. PubMed ID: 8585026
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
    Dahlbäck B
    J Lab Clin Med; 1995 May; 125(5):566-71. PubMed ID: 7738422
    [No Abstract]   [Full Text] [Related]  

  • 33. [APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].
    Hakala L; Vahtera E; Krusius T; Rasi V
    Duodecim; 1995; 111(22):2143-51. PubMed ID: 9841174
    [No Abstract]   [Full Text] [Related]  

  • 34. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B; He X; Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K; Dahlbäck B; Nicolaes GA
    Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 38. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activated protein C resistance (APC resistance)].
    Gohchi K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():678-80. PubMed ID: 15658422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.